These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 80488)

  • 21. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Value of the determination of activated coagulation time for decreasing heparin and protamine sulfate doses during operations with artificial circulation].
    Savina ME; Piatnitskaia GK; Kukaeva EA; Charnaia MA; Charnyĭ ISh
    Anesteziol Reanimatol; 1981; (5):52-6. PubMed ID: 7325386
    [No Abstract]   [Full Text] [Related]  

  • 23. [The plasma-protamine-paracoagulation-(3-P-) test].
    Berkessy S
    Z Gesamte Inn Med; 1974 Jun; 29(12):491-3. PubMed ID: 4849942
    [No Abstract]   [Full Text] [Related]  

  • 24. [Heparin activity before and after iodized salt-water balneotherapy with protamine sulfate index and coagulation time].
    FORTUNA A
    Arch Med Interna; 1959; 11():225-34. PubMed ID: 13824073
    [No Abstract]   [Full Text] [Related]  

  • 25. Persistent spontaneous heparinaemia in systemic mastocytosis.
    Nenci GG; Berrettini M; Parise P; Agnelli G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(3):453-63. PubMed ID: 6182065
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of paracoagulation tests with Merskey's test].
    Malanowicz W; Skarzyńska M
    Pol Tyg Lek; 1978 May; 33(18):713-6. PubMed ID: 662770
    [No Abstract]   [Full Text] [Related]  

  • 27. Polybrene neutralization as a rapid means of monitoring blood heparin levels.
    Grann VR; Homewood K; Golden W
    Am J Clin Pathol; 1972 Jul; 58(1):26-32. PubMed ID: 5034651
    [No Abstract]   [Full Text] [Related]  

  • 28. [Determination of the amount of heparin in the blood by titration with protamine sulfate].
    Kaluzhenko RK; Murchakova AF
    Lab Delo; 1966; 7():392-3. PubMed ID: 4170776
    [No Abstract]   [Full Text] [Related]  

  • 29. [Specificity and sensitivity of paracoagulation tests].
    Litvinov RI; Voronina IE; Gabitov SE
    Lab Delo; 1980; (11):662-6. PubMed ID: 6160297
    [No Abstract]   [Full Text] [Related]  

  • 30. Monitoring of intraoperative heparinization and blood loss following cardiopulmonary bypass surgery.
    Babka R; Colby C; El-Etr A; Pifarré R
    J Thorac Cardiovasc Surg; 1977 May; 73(5):780-2. PubMed ID: 850438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Method of control of the artificial heparinization of blood].
    Iunovidova LI; Savina ME; Kukaeva EA
    Lab Delo; 1985; (11):657-9. PubMed ID: 2417016
    [No Abstract]   [Full Text] [Related]  

  • 32. [Control of temporary anticoagulation in extracorporeal circulation using activated coagulation time].
    Kessler G; Grünes G
    Anaesthesist; 1984 Dec; 33(12):588-91. PubMed ID: 6528961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin administration during extracorporeal circulation: heparin rebound and postoperative bleeding.
    Kaul TK; Crow MJ; Rajah SM; Deverall PB; Watson DA
    J Thorac Cardiovasc Surg; 1979 Jul; 78(1):95-102. PubMed ID: 449391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the activated clotting time in heparin administration and neutralization for cardiopulmonary bypass.
    Esposito RA; Culliford AT; Colvin SB; Thomas SJ; Lackner H; Spencer FC
    J Thorac Cardiovasc Surg; 1983 Feb; 85(2):174-85. PubMed ID: 6823136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of "in vitro" degradation of protamine in plasma by three different methods.
    Weiss M; Blass J; Detruit H; Aime L; Baudet B; Fiancette JY; Gaillard M; Vicaigne MB; Verriest C
    Thromb Res; 1986 Mar; 41(5):593-604. PubMed ID: 3961737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rate of protamine administration: its effect on heparin reversal and antithrombin recovery after coronary artery surgery.
    Zaidan JR; Johnson S; Brynes R; Monroe S; Guffin AV
    Anesth Analg; 1986 Apr; 65(4):377-80. PubMed ID: 3954111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Heparinization control by activated coagulation time in cardiac surgery with extracorporeal circulation].
    Daudt CA; Pereira SN; Moraes LB; Costa PS; Deboni LM; Figueiredo MS
    Arq Bras Cardiol; 1989 Mar; 52(3):137-9. PubMed ID: 2597000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 40. [Control of the therapeutic heparin dosage in platelet rich citrate plasma after protamine neutralization].
    Görss EW; Maercker W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(6):815-22. PubMed ID: 2436996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.